Trial Profile
A Randomized, Controlled Trial Assessing Long-Term Effect Of AST-120 On Renal Disease Progression In Patients With Advanced Chronic Kidney Disease (CKD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Charcoal (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 15 Mar 2017 New trial record